Life settlement investment risks explained 2026: the 6 real risks and how HYV mitigates them.

The 6 primary risks of life settlement investing are longevity (insured living longer than projected life expectancy), liquidity (no secondary market for individual policies), carrier credit (insurance company insolvency), premium (ongoing premium costs affecting net economics), regulatory (state-level rules can evolve), and servicing (documentation or execution errors). Longevity is the largest single risk — each additional year beyond projected LE typically reduces IRR by 100-200 basis points. All 6 risks are manageable through institutional frameworks including independent LE provider triangulation, A-rated carrier selection, premium optimization at acquisition, operations only in NAIC-aligned jurisdictions, and institutional custodian coordination. Life settlements are not FDIC insured and involve risk of loss of capital.

Life settlements are not "safe" in the sense of guaranteed return — no alternative investment is. They are a well-established institutional asset class with quantifiable, well-understood risks and mature mitigation frameworks. Compared to public equities, life settlements offer zero correlation to market volatility and contractual return at maturity, but at the cost of illiquidity and longevity uncertainty. Compared to bonds, life settlements offer higher target returns (8-12% target IRR vs. 4-5% investment-grade bonds) but with materially longer duration and no periodic income. Institutional allocators including Apollo, Berkshire Hathaway, and Partner Re have deployed billions into the asset class specifically because the risk-adjusted return profile — when managed through proper institutional frameworks — competes favorably with other alternatives. For accredited investors who can accept 5-10+ year illiquidity and understand longevity risk, life settlements can be a valuable portfolio addition. They are not appropriate for capital that may be needed short-term or for investors unable to accept potential loss.

Extended life expectancy — longevity risk — is the single largest risk in life settlement investing. When an insured lives beyond the projected LE, two effects compound: (1) the eventual return is discounted over a longer time frame, reducing IRR by approximately 100-200 basis points per year of extension; (2) additional premium payments during the extended hold period further reduce net return. Institutional mitigation approaches include: using independent LE providers (like ITM TwentyFirst and 21st Services) with track records of conservative estimation, triangulating across multiple LE providers rather than relying on single estimates, and diversifying acquisition across policies with staggered LE profiles so that longevity variance smooths at the portfolio level (Wharton research shows portfolios of 100+ policies reduce return standard deviation by over 40% vs portfolios of 10 or fewer). Individual investors can build meaningful diversification within a $500K-$2M allocation across 2-6 policies with different LE profiles.

Yes — total loss of capital is possible under specific adverse scenarios, though it is not the typical outcome. Total loss scenarios include: policy lapse due to non-payment of premiums (eliminates all return); severe carrier insolvency below state guaranty association coverage limits ($250K-$500K depending on state); or serious servicing errors that invalidate the policy. Institutional mitigation reduces total loss probability substantially: HYV operates with A-rated AM Best carriers only (dramatically reducing carrier insolvency risk), institutional custodian coordination for premium execution (reducing lapse risk from operational error), and documented ownership records (reducing servicing invalidation risk). More typical adverse outcomes are reduced returns (below target 8-12% IRR range) rather than total capital loss — driven primarily by longevity extension. All investors should size life settlement allocations at a level where potential adverse outcomes fit within their overall portfolio risk tolerance. Life settlement investments are not FDIC insured and involve substantial risk.

Direct ownership reduces 4 of the 6 risk vectors relative to pooled fund structures. Longevity risk: you control which policies you acquire and can build diversification across LE profiles matching your specific risk tolerance rather than inheriting a manager's selection bias. Carrier credit risk: you see and select every carrier — HYV limits acquisition to A-rated AM Best carriers only, transparent on every listing. Premium risk: you fund your own policies through your custodian; no exposure to shared premium reserves where other investors' failure to fund can trigger policy issues. Servicing risk: you have owner-level visibility on every policy status; institutional custodian coordination handles execution but you remain owner of record. Direct ownership does not reduce liquidity risk (both have similar hold periods) or regulatory risk (same state-level framework applies). Direct ownership also eliminates fund manager fee-drag (typically 1-2% annual + performance fees) that meaningfully compresses net returns under fund structures — this isn't a "risk" reduction technically, but it does improve net return economics substantially.

Every specific policy carries a discrete risk profile you can evaluate before committing capital. Key evaluation points include: (1) LE reports from recognized independent underwriters — look for multiple LE providers rather than single-source estimates, and consider the range of estimates rather than just the point projection; (2) carrier financial strength — AM Best rating of A or better is the institutional standard; (3) premium schedule — annual premium efficiency under 4% of face value is the standard threshold for policy-level acquisition; (4) contestability status — policies past the 2-year contestability window carry substantially reduced acquisition risk; (5) policy type — universal life and guaranteed universal life are the standard institutional acquisition types; (6) insured age and health profile — the standard institutional acquisition range is age 75+ with documented medical impairments supporting the LE projection. HYV's policy scoring framework applies all 6 criteria to every listing — see the full scoring framework or schedule a consultation to walk through a specific policy's risk profile with an advisor.